Page 136 - MSU Digital Book

22. Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, et al.

2019 Update of the Joint European League Against Rheumatism and European
Renal Association-European Dialysis and Transplant Association EULAR/ERA-EDTA)
recommendations for the management of lupus nephritis. Ann Rheum Dis.

2020;79:713-23.
23. Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint

European League Against Rheumatism and European Renal Association-European
Dialysis and Transplant Association EULAR/ERA-EDTA) recommendations for
the management of adult and paediatric lupus nephritis. Ann Rheum Dis.

2012;71:1771-82.
24. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et

al. American College of Rheumatology guidelines for screening, treatment, and
management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64:797-808.
25. Lee SJ, Silverman E, Bargman JM. The role of antimalarial agents in the treatment

of SLE and lupus nephritis. Nat Rev Nephrol. 2011;7:718-29.
26. Kostopoulou M, Fanouriakis A, Cheema K, Boletis J, Bertsias G, Jayne D, et al.

Management of lupus nephritis: a systematic literature review informing the
2019 update of the joint EULAR and European Renal Association-European
Dialysis and Transplant Association EULAR/ERA-EDTA) recommendations. RMD

Open. 2020;6:e001263.
27. Zhong Z, Li H, Zhong H, Zhou T. Clinical efficacy and safety of rituximab in lupus

nephritis. Drug Des Devel Ther. 2019;13:845-56.
28. de Groot K, Harper L, Jayne DR et al. Pulse versus daily oral cyclophosphamide for
induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis:

a randomized trial. Ann Intern Med 2009;150:670–80.
29. Walters GD, Willis NS, Craig JC. Interventions for renal vasculitis in adults. Cochrane

Database Syst Rev. 2015:CD003232.
30. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J,
et al. 2014 evidence-based guideline for the management of high blood pressure

in adults: report from the panel members appointed to the Eighth Joint National
Committee (JNC 8). JAMA. 2014;311:507-20.

111